[8] Characterization of factor IX defects in hemophilia B patients
- 1 January 1993
- book chapter
- Published by Elsevier
- Vol. 222, 143-169
- https://doi.org/10.1016/0076-6879(93)22011-4
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Evidence that descendants of three founders constitute about 25% of hemophilia B in the united statesGenomics, 1991
- Sequence-specific 1H NMR assignments, secondary structure, and location of the calcium binding site in the first epidermal growth factor like domain of blood coagulation factor IXBiochemistry, 1991
- Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneityBritish Journal of Haematology, 1991
- The molecular genetics of familial venous thrombosisBlood Reviews, 1991
- "Founder" effect in different families with haemophilia B mutationThe Lancet, 1990
- Direct sequencing of the activation peptide and the catalytic domain of the factor IX gene in six speciesGenomics, 1990
- Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.Journal of Clinical Investigation, 1989
- Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion.Journal of Clinical Investigation, 1986
- An intragenic deletion of the factor IX gene in a family with hemophilia B.Journal of Clinical Investigation, 1985
- Hemophilia B LeydenNew England Journal of Medicine, 1982